GYRE
Gyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
Gyre Therapeutics (GYRE) Earnings
Gyre Therapeutics (GYRE) released its earnings on Nov 7, 2025: revenue was 30.56M (YoY +19.92%), missed estimates; EPS was 0.03 (YoY +200.00%), missed estimates.
Revenue / YoY
30.56M
+19.92%
EPS / YoY
0.03
+200.00%
Report date
Nov 7, 2025
EPS
Actual | -4.2 | -14.4 | -10.95 | -12.9 | -11.85 | -9.6 | -12 | -9.75 | -6.9 | 24.6 | -19.05 | -1.05 | 0.03 | 0.01 | 0.01 | 0 | 0 | 0 | 0.03 | |||||||||||
Forecast | -5.475 | -12.9375 | -12.1 | -12.9375 | -8.6625 | -10.425 | -9.9 | -8.8125 | -6.85 | -3.675 | -1.575 | -1.05 | -0.75 | 0.04 | 0.03 | 0.03 | 0.0467 | |||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +23.29% | -11.30% | +9.50% | +0.29% | -36.80% | +7.91% | -21.21% | -10.64% | -0.73% | +769.39% | -1109.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -100.00% | -100.00% | -35.76% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.37M | 1.66M | 893.00K | 2.00M | 1.47M | 1.13M | 2.30M | 2.44M | 794.00K | 0 | 0 | 0 | -- | -- | 27.17M | 25.23M | 25.49M | 27.87M | 22.06M | 26.77M | 30.56M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.95M | 300.00K | 2.10M | 50.00K | 1.07M | 333.33K | 675.00K | 166.67K | 797.00K | 0 | 400.00K | 0 | 0 | -- | -- | -- | -- | 23.50M | 28.40M | 30.80M | 32.93M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +105.91% | +452.67% | -57.48% | +3900.00% | +37.53% | +239.60% | +240.59% | +1362.80% | -0.38% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +18.60% | -22.33% | -13.08% | -7.18% |
Earnings Call
You can ask Aime
Did Gyre Therapeutics beat or miss consensus estimates last quarter?What is Gyre Therapeutics's gross profit margin?What does Gyre Therapeutics do and what are its main business segments?What were the key takeaways from Gyre Therapeutics's earnings call?What guidance did Gyre Therapeutics's management provide for the next earnings period?What factors drove the changes in Gyre Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Gyre Therapeutics year over year?What is the market's earnings forecast for Gyre Therapeutics next quarter?
